AI Verdict
PBH has stronger fundamentals based on our AI analysis.
PBH vs PAYO Fundamental Comparison
| Metric | PBH | PAYO |
|---|---|---|
| Revenue | $807.1M | $1.1B |
| Net Income | $136.4M | $73.2M |
| Net Margin | 16.9% | 7.0% |
| ROE | 7.5% | 10.4% |
| ROA | 3.9% | 0.8% |
| Current Ratio | 3.11x | 1.00x |
| Debt/Equity | 0.56x | 0.02x |
| EPS | $2.78 | $0.19 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PBH vs PAYO: Frequently Asked Questions
Is PBH or PAYO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PBH has stronger fundamentals. PBH is rated BUY (65% confidence) while PAYO is rated HOLD (72% confidence). This is not investment advice.
How does PBH compare to PAYO fundamentally?
Prestige Consumer Healthcare Inc. has ROE of 7.5% vs Payoneer Global Inc.'s 10.4%. Net margins are 16.9% vs 7.0% respectively.
Which stock pays higher dividends, PBH or PAYO?
PBH has a dividend yield of N/A or no dividend while PAYO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PBH or PAYO for long term?
For long-term investing, consider that PBH has BUY rating with 65% confidence, while PAYO has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PBH vs PAYO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PBH vs PAYO, the AI consensus favors PBH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.